Corruption probe sees China sales plummet for Glaxo

Drugs giant GlaxoSmithKline has revealed a corruption probe in China sent sales of pharmaceuticals and vaccines in the country plummeting 61%.

Shares in the maker of Sensodyne, Panadol and Aquafresh dropped 2% after it reported the sales blow and a 6% pre-tax profits fall to £1.4bn during the three months to the end of September.